Literature DB >> 30636530

Serum indirect immunofluorescence assay and real-time PCR results in dogs affected by Leishmania infantum: evaluation before and after treatment at different clinical stages.

Barbara Bruno1,2, Angelo Romano1,2, Renato Zanatta1,2, Simona Spina1,2, Walter Mignone1,2, Francesco Ingravalle1,2, Paola Barzanti1,2, Lara Ceccarelli1,2, Maria Goria1,2.   

Abstract

We compared results of a serum immunofluorescence assay (IFA) and lymph node quantitative PCR (qPCR) in dogs classified as exposed, infected, or sick because of leishmaniasis. We also determined how IFA or qPCR results changed in response to treatment and reflected different clinical and clinicopathologic improvement of dogs. We included 108 dogs in our retrospective study: 12 exposed, 25 infected, and 71 sick, as classified according to Canine Leishmaniasis Working Group standards. Between-group comparison showed higher IFA values ( p < 0.01) for sick dogs; qPCR values were higher for sick than infected dogs ( p < 0.01). A novel clinical and clinicopathologic score was created and applied to 50 sick dogs. Using this score, 41 were reclassified as partially recovered (PR) within 3 mo, and 37 as totally recovered (TR) 3-6 mo after presentation. Statistically significant differences in IFA values were found between the sick and TR dogs ( p < 0.01), but not between sick and PR dogs ( p = 0.98). During follow-up, qPCR revealed a progressive decrease in parasite load, with a statistically significant difference in sick versus PR ( p < 0.01), sick versus TR ( p < 0.01), and PR versus TR ( p < 0.01) dogs. A decrease of 1 point in the clinical score corresponded to 1.3 Leishmania/μL qPCR decrease ( p < 0.01) and decrease of 1:42 in IFA ( p < 0.01). Our findings confirm that the clinical status of dogs affected by leishmaniasis is closely related to parasite load and antibody level, both before and after treatment.

Entities:  

Keywords:  Clinical score; dogs; indirect immunofluorescence assay; leishmaniasis; qPCR

Mesh:

Substances:

Year:  2019        PMID: 30636530      PMCID: PMC6838825          DOI: 10.1177/1040638718824140

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  19 in total

1.  Guidelines for diagnosis and clinical classification of leishmaniasis in dogs.

Authors:  Saverio Paltrinieri; Laia Solano-Gallego; Alessandra Fondati; George Lubas; Luigi Gradoni; Massimo Castagnaro; Alberto Crotti; Michele Maroli; Gaetano Oliva; Xavier Roura; Andrea Zatelli; Eric Zini
Journal:  J Am Vet Med Assoc       Date:  2010-06-01       Impact factor: 1.936

Review 2.  Guidelines for treatment of leishmaniasis in dogs.

Authors:  Gaetano Oliva; Xavier Roura; Alberto Crotti; Michele Maroli; Massimo Castagnaro; Luigi Gradoni; George Lubas; Saverio Paltrinieri; Andrea Zatelli; Eric Zini
Journal:  J Am Vet Med Assoc       Date:  2010-06-01       Impact factor: 1.936

3.  Multicentric, controlled clinical study to evaluate effectiveness and safety of miltefosine and allopurinol for canine leishmaniosis.

Authors:  Guadalupe Miró; Gaetano Oliva; Israel Cruz; Carmen Cañavate; Michele Mortarino; Claudia Vischer; Paolo Bianciardi
Journal:  Vet Dermatol       Date:  2009-10       Impact factor: 1.589

4.  Clinical considerations on canine visceral leishmaniasis in Greece: a retrospective study of 158 cases (1989-1996).

Authors:  A F Koutinas; Z S Polizopoulou; M N Saridomichelakis; D Argyriadis; A Fytianou; K G Plevraki
Journal:  J Am Anim Hosp Assoc       Date:  1999 Sep-Oct       Impact factor: 1.023

5.  Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas. Evolution in the course of infection and after treatment.

Authors:  L Solano-Gallego; C Riera; X Roura; L Iniesta; M Gallego; J E Valladares; R Fisa; S Castillejo; J Alberola; L Ferrer; M Arboix; M Portús
Journal:  Vet Parasitol       Date:  2001-04-19       Impact factor: 2.738

Review 6.  Laboratory tests for diagnosing and monitoring canine leishmaniasis.

Authors:  Saverio Paltrinieri; Luigi Gradoni; Xavier Roura; Andrea Zatelli; Eric Zini
Journal:  Vet Clin Pathol       Date:  2016-11-02       Impact factor: 1.180

7.  Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantum.

Authors:  E Pinelli; R Killick-Kendrick; J Wagenaar; W Bernadina; G del Real; J Ruitenberg
Journal:  Infect Immun       Date:  1994-01       Impact factor: 3.441

8.  Advantages of real-time PCR assay for diagnosis and monitoring of canine leishmaniosis.

Authors:  O Francino; L Altet; E Sánchez-Robert; A Rodriguez; L Solano-Gallego; J Alberola; L Ferrer; A Sánchez; X Roura
Journal:  Vet Parasitol       Date:  2006-02-13       Impact factor: 2.738

Review 9.  Directions for the diagnosis, clinical staging, treatment and prevention of canine leishmaniosis.

Authors:  L Solano-Gallego; A Koutinas; G Miró; L Cardoso; M G Pennisi; L Ferrer; P Bourdeau; G Oliva; G Baneth
Journal:  Vet Parasitol       Date:  2009-06-06       Impact factor: 2.738

10.  LeishVet guidelines for the practical management of canine leishmaniosis.

Authors:  Laia Solano-Gallego; Guadalupe Miró; Alek Koutinas; Luis Cardoso; Maria Grazia Pennisi; Luis Ferrer; Patrick Bourdeau; Gaetano Oliva; Gad Baneth
Journal:  Parasit Vectors       Date:  2011-05-20       Impact factor: 3.876

View more
  1 in total

1.  Monitoring of serum and urinary biomarkers during treatment of canine visceral leishmaniasis.

Authors:  Alvaro Felipe de Lima Ruy Dias; Eveline da Cruz Boa Sorte Ayres; Fernanda Harumi Maruyama; Bruna Ribeiro Gomes Monteiro; Maria Sabrina de Freitas; Arleana do Bom Parto Ferreira de Almeida; Adriane Jorge Mendonça; Valéria Régia Franco Sousa
Journal:  Vet World       Date:  2020-08-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.